Abstract
NPC is an Epstein-Barr virus (EBV)-associated disease. EBV plays a pivotal role in tumor initiation and progression. It is well known that immune-suppression contribute to the initiation and progression of NPC and the immune function is correlated with the prognosis of NPC patients. However, the association of EBV infection status with peripheral immune parameters and clinical outcome in patients with advanced NPC is still not fully clear.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
